Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4

Cancer Research

Volumn 73, Issue 2, 2013, Pages 1011-1019

  Burikhanov, Ravshan ^a   Shrestha Bhattarai, Tripti ^b   Qiu, Shirley ^a   Shukla, Nidhi ^a   Hebbar, Nikhil ^b   Lele, Subodh M ^d   Horbinski, Craig ^b   Rangnekar, Vivek M ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEINASE ACTIVATED RECEPTOR 4; UACA PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN TRANSPORT; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOANTIGENS; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; ENDOPLASMIC RETICULUM; EXTRACELLULAR SPACE; HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; NF-KAPPA B; PROTEIN TRANSPORT; RECEPTORS, PROTEINASE-ACTIVATED; SIGNAL TRANSDUCTION;

EID: 84872509120     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3212     Document Type: Article

References (13)

1. Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze SR, Rangnekar VM. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell 2009;138: 377-88.
2. Gurumurthy S, Goswami A, Vasudevan KM, Rangnekar VM. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis. Mol Cell Biol 2005;25: 1146-61.
3. Zhao Y, Burikhanov R, Brandon J, Qiu S, Shelton BJ, Spear B, et al. Systemic Par-4 inhibits non-autochthonous tumor growth. Cancer Biol Ther 2011;12: 152-7.
4. Gilmore TD, Garbati MR. Inhibition of NF-kappaB signaling as a strategy in disease therapy. Curr Top Microbiol Immunol 2011;349: 245-63.
5. Kim HJ, Hawke N, Baldwin AS. NF-kappaB and IKK as therapeutic targets in cancer. Cell Death Differ 2006;13: 738-47.
6. Misra UK, Mowery Y, Kaczowka S, Pizzo SV. Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis. Mol Cancer Ther 2009;8: 1350-62.
7. Yamada K, Senju S, Nakatsura T, Murata Y, Ishihara M, Nakamura S, et al. Identification of a novel autoantigen UACA in patients with panuveitis. Biochem Biophys Res Commun 2001;280: 1169-76.
8. Ni M, Zhang Y, Lee AS. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem J 2011;434: 181-8.
9. Cook KL, Shajahan AN, Wärri A, Jin L, Hilakivi-Clarke LA, Clarke R. Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness. Cancer Res 2012;72: 3337-49.
10. Grkovic S, O'Reilly VC, Han S, Hong M, Baxter RC, Firth SM. IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments. Oncogene. 2012 Jul 2. [Epub ahead of print].
11. Sato M, Yao VJ, Arap W, Pasqualini R. GRP78 signaling hub a receptor for targeted tumor therapy. Adv Genet 2010;69: 97-114.
12. Moravcikova E, Krepela E, Prochazka J, Rousalova I, Cermak J, Kenkova K. Down-regulated expression of apoptosis-associated genes APIP and UACA in non-small cell lung carcinoma. Int J Oncol 2012;4: 2111-21.
13. Sakai T, Liu L, Teng X, Ishimaru N, Mukai-Sakai R, Tran NH, et al. Inflammatory disease and cancer with a decrease in Kupffer cell numbers in Nucling-knockout mice. Int J Cancer 2010;126: 1079-94.